Hepatic fibrosis and cytochrome P450: Experimental models of fibrosis compared to AHR knockout mice

Hepatology Research

Volumn 17, Issue 2, 2000, Pages 112-125

  Peterson, Theresa C ^a,b   Hodgson, Paul ^b   Fernandez Salguero, Pedro ^c   Neumeister, Michael ^b   Gonzalez, Frank J ^c  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; CYTOCHROME P450; MALACHITE GREEN; MESSENGER RNA; PHENACETIN O DEETHYLASE; PHOSPHORUS; UNSPECIFIC MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; COLLAGEN DEGRADATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DRUG METABOLISM; ENZYME ACTIVITY; EXPERIMENTAL MODEL; KNOCKOUT MOUSE; LIVER FIBROSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SERUM; STAINING; SWINE; TISSUE SECTION; TRANSGENIC MOUSE;

EID: 0034106077     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(99)00068-6     Document Type: Article

References (29)

1. Peterson T.C., Williams C.N. Depression of peripheral blood monocyte arylhydrocarbon hydroxylase activity in patients with cirrhosis: possible role of macrophage factors. Hepatology. 7(2):1987;333-337.
2. Putnam A.D., Peterson T.C. Effect of aging and other factors on monocyte AHH activity. Mech. Aging Dev. 60:1991;61-74.
3. Peterson T.C. Monocyte arylhydrocarbon hydroxylase activity and mortality. Clin. Invest. Med. 14(1):1991;72-76.
4. Peterson T.C., Williams C.N., Malatjalian D.A. Monocyte arylhydrocarbon hydroxylase (AHH) activity mimics Kupffer cell and hepatocyte AHH activity in an animal model of liver disease. Can. J. Physiol. Pharmacol. 69:1991;1707-1803.
5. Peterson T.C., Neumeister M. Effect of pentoxifylline in rat and swine models of hepatic fibrosis: role of fibroproliferation in its mechanism. Immunopharmacology. 31:1996;183-193.
6. Orellana M., Avalos N., Abarca M., Valdes E. Microsomal and peroxisomal fatty acid oxidation in bile duct ligated rats: a comparative study between liver and kidney. Gen. Pharmacol. 28:1997;525-529.
7. Fernandez-Salguero P., Pineau T., Hilbert D., McPhail T., Lee S., Kimura S., Nebert D. et al. Immune system impairment and hepatic fibrosis in mice lacking the dioxin binding Ah receptor. Science. 268:1995;722-726.
8. Okey A.B., Riddick D.S., Harper P.A. Molecular biology of the aromatic hydrocarbon (dioxin) receptor. Trends Pharmacol. Sci. 15:1994;226-232.
9. Butler M.A., Iwasaki M., Guengerich F., Kadlubar F. Human cytochrome P450 PA (P450 1A2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N oxidation of carcinogenic arylamines. Proc. Natl. Acad. Sci. USA. 86:1989;7696-7700.
10. Hodgson P.D., Peterson T.C. Effect of pentoxifylline in a heterologous serum model of fibrosis in the rat. Hepatology. 22:1995;4.
11. Peterson T.C. Pentoxifylline prevents fibrosis in an animal model and inhibits platelet-derived growth factor-driven proliferation of fibroblasts. Hepatology. 17:1993;486-493.
12. Paronetto F., Popper H. Chronic liver injury induced by immunologic reactions. Am. J. Pathol. 49:1966;1087-1096.
13. Lopez-de Leon R. A simple micromethod for collagen and total protein determination in formalin fixed paraffin embedded sections. J. Histochem. Cytochem. 33:1985;737-743.
14. Gascon-Barre M., Huet P.-M., Belgiorno J., Plourde V., Coulombe P.A. Estimation of collagen content in liver specimens. Variation among animals and among hepatic lobes in cirrhotic rats. J. Histochem. Cytochem. 37:1989;377-381.
15. Zar J.H. Biostatistical methods. 1974;Prentice-Hall, Englewood Cliffs, NJ.
16. McDonnell W.M., Chensue S.W., Askari F.K., Moseley R.H. Hepatic fibrosis in Ahr-/- mice. Science. 271:1996;223-224.
17. Davis B.H., Rapp U.R., Davidson N.O. Retinoic acid and transforming growth factor beta differentially inhibit platelet derived growth factor induced Ito cell activation. Biochem. J. 278:1991;43-47.
18. Gressner A., Polzar B., Lahme B., Mannherz H. Induction of rat liver parenchymal cell apoptosis by hepatic myofibroblasts via transforming growth factor β Hepatology. 23:1996;571-581.
19. Patel T., Gores G.J. Apoptosis and hepatobiliary disease. Hepatology. 21:1995;1725-1741.
20. Peterson T.C., Fernandez-Salguero F., Gonzalez F.J. Collagen deposition and apoptosis in livers of AHR knockout mice. Can. J. Gastroenterol. 11((Suppl A)):1997;62A.
21. Palmer C., Coates P., Davies S., Shephard E., Phillips I. Localization of cytochrome P450 gene expression in normal and diseased human liver by in situ hybridization of wax-embedded archival material. Hepatology. 16:1992;682-687.
22. Ratanasavanh D., Beaune P., Morel F., Flinois J., Guengerich F., Guillouzo A. Intralobular distribution and quantitation of cytochrome P450 enzymes in human liver as a function of age. Hepatology. 13:1991;1142-1151.
23. 4-induced fibrotic rat livers. Hepatology. 23:1996;1538-1545.
24. Schmidt J.V., Su G.H., Reddy J.K., Simon M.C., Bradfield C. Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. Proc. Natl. Acad. Sci. USA. 25(93):1996;6731-6736.
25. George J., Murray M., Byth K., Farrell G. Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease. Hepatology. 21:1995;120-128.
26. Peterson T.C. Interleukin-1, free radicals and monocyte arylhydrocarbon hydroxylase activity in liver disease: role of cell communication. Biochem. Pharmacol. 43:1992;1163-1166.
27. Abdel-Razzak Z., Corcos I., Fautrel A., Campion J.-P., Guillouzo A. Transforming growth-factor-beta-1 down regulates basal and polycyclic aromatic hydrocarbon-induced cytochromes P-450 1A1 and 1A2 in adult hepatocytes in primary culture. Mol. Pharmacol. 46:1994;1100-1110.
28. Okuno H., Hazama H., Murase T., Shiozaki Y., Sameshima Y. Drug metabolizing activity in rats with chronic liver injury induced by carbon tetrachloride: relationship with the content of hydroxyproline in the liver. Jpn. J. Pharmacol. 41:1986;363-371.
29. Gonzalez F.J., Fernandez-Salguero P. The aryl hydrocarbon receptor. Drug Metab. Dispos. 26(12):1998;1194-1198.